Fortrea Holdings Inc
FTRE10.650USD
+0.340+3.30%
Close 09/18, 16:00（ET）Quotes delayed by 15 min
967.02MMarket Cap
LossP/E TTM
More Details of Fortrea Holdings Inc Company
Fortrea Holdings Inc. is a global contract research organization (CRO), which provides clinical development solutions to the life sciences industry. The Company is engaged in providing biopharmaceutical product and medical device development services to pharmaceutical, biotechnology and medical device customers. The Company offers customers flexible delivery models that include full service, functional service provider, and hybrid service structures. It provides phase I-IV clinical trial management, clinical pharmacology and consulting services. The Company manages its business through a single segment, Clinical Services, that provides services across the clinical pharmacology and clinical development spectrum. The Company has access to all key markets worldwide through a footprint of primary office locations in five countries (the United States, the United Kingdom, China, India and Singapore) with field operations in other jurisdictions worldwide.
Company Info
Ticker SymbolFTRE
Company nameFortrea Holdings Inc
IPO dateJun 16, 2023
CEOMr. Anshul Thakrala
Number of employees15500
Security typeOrdinary Share
Fiscal year-endJun 16
Address8 Moore Drive
CityDURHAM
Stock exchangeNASDAQ Global Select Consolidated
CountryUnited States of America
Postal code27709
Phone18774950816
Websitehttps://www.fortrea.com/
Ticker SymbolFTRE
IPO dateJun 16, 2023
CEOMr. Anshul Thakrala
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. Peter M. Neupert
Mr. Peter M. Neupert
Chairman of the Board
Chairman of the Board
98.13K
+175.40%
Dr. Amrit Ray, M.D.
Dr. Amrit Ray, M.D.
Lead Independent Director
Lead Independent Director
13.64K
+114.60%
Mr. Edward A. Pesicka
Mr. Edward A. Pesicka
Independent Director
Independent Director
13.64K
+114.60%
Mr. David Ross Smith
Mr. David Ross Smith
Independent Director
Independent Director
9.54K
+114.62%
Ms. Machelle Sanders
Ms. Machelle Sanders
Independent Director
Independent Director
7.28K
--
Ms. Jill Mcconnell
Ms. Jill Mcconnell
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Mark Morais
Mr. Mark Morais
Chief Operating Officer and President - Clinical Services
Chief Operating Officer and President - Clinical Services
--
--
Ms. Erin L. Russell
Ms. Erin L. Russell
Independent Director
Independent Director
--
--
Ms. Hima B. Inguva
Ms. Hima B. Inguva
Investor Relations
Investor Relations
--
--
Mr. Anshul Thakrala
Mr. Anshul Thakrala
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Peter M. Neupert
Mr. Peter M. Neupert
Chairman of the Board
Chairman of the Board
98.13K
+175.40%
Dr. Amrit Ray, M.D.
Dr. Amrit Ray, M.D.
Lead Independent Director
Lead Independent Director
13.64K
+114.60%
Mr. Edward A. Pesicka
Mr. Edward A. Pesicka
Independent Director
Independent Director
13.64K
+114.60%
Mr. David Ross Smith
Mr. David Ross Smith
Independent Director
Independent Director
9.54K
+114.62%
Ms. Machelle Sanders
Ms. Machelle Sanders
Independent Director
Independent Director
7.28K
--
Ms. Jill Mcconnell
Ms. Jill Mcconnell
Chief Financial Officer
Chief Financial Officer
--
--
Revenue Breakdown
Currency: USDUpdated: Sun, Jul 6
Currency: USDUpdated: Sun, Jul 6
FY2025Q1
FY2024
FY2024Q4
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q3
FY2022Q2
FY2021
FY2020
No Data
By RegionUSD
Name
Revenue
Proportion
North America
309.50M
47.52%
Europe
200.30M
30.75%
Other
141.50M
21.73%
By Business
By Region
No Data
Shareholding Stats
Updated: Sat, Aug 16
Updated: Sat, Aug 16
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
14.03%
The Vanguard Group, Inc.
9.37%
Goldman Sachs & Company, Inc.
8.53%
AQR Capital Management, LLC
7.18%
Corvex Management LP
4.97%
Other
55.93%
Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
14.03%
The Vanguard Group, Inc.
9.37%
Goldman Sachs & Company, Inc.
8.53%
AQR Capital Management, LLC
7.18%
Corvex Management LP
4.97%
Other
55.93%
Shareholder Types
Shareholders
Proportion
Investment Advisor
46.00%
Hedge Fund
24.41%
Investment Advisor/Hedge Fund
22.94%
Research Firm
13.87%
Bank and Trust
2.55%
Pension Fund
2.42%
Individual Investor
0.52%
Family Office
0.39%
Sovereign Wealth Fund
0.05%
Institutional Shareholding
Updated: Tue, Jul 1
Updated: Tue, Jul 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
941
91.16M
100.39%
-22.39M
2025Q1
942
95.79M
105.84%
-17.15M
2024Q4
898
97.88M
109.12%
-17.67M
2024Q3
853
101.51M
113.29%
-12.93M
2024Q2
825
103.91M
116.10%
+693.93K
2024Q1
782
93.40M
104.47%
-524.01K
2023Q4
716
91.67M
103.23%
-7.08M
2023Q3
616
90.69M
102.13%
+51.44M
2023Q2
43
6.20M
7.00%
+6.20M
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
BlackRock Institutional Trust Company, N.A.
10.95M
12.1%
-180.41K
-1.62%
Mar 31, 2025
The Vanguard Group, Inc.
9.85M
10.88%
+12.67K
+0.13%
Mar 31, 2025
AQR Capital Management, LLC
1.10M
1.21%
+706.78K
+181.92%
Mar 31, 2025
Corvex Management LP
4.47M
4.94%
+994.00K
+28.56%
Mar 31, 2025
State Street Global Advisors (US)
3.26M
3.61%
-107.87K
-3.20%
Mar 31, 2025
Sessa Capital
4.69M
5.19%
-1.96M
-29.51%
Mar 31, 2025
Fidelity Management & Research Company LLC
4.05M
4.48%
-2.13M
-34.48%
Mar 31, 2025
Starboard Value LP
2.72M
3%
-2.55M
-48.44%
May 12, 2025
Geode Capital Management, L.L.C.
1.58M
1.75%
+87.80K
+5.88%
Mar 31, 2025
View more
Related ETFs
Updated: Sat, Sep 6
Updated: Sat, Sep 6
Name
Proportion
Humankind US Stock ETF
0.14%
Invesco S&P SmallCap 600 QVM Multi-factor ETF
0.06%
Vanguard US Value Factor ETF
0.04%
iShares Morningstar Small-Cap Value ETF
0.03%
WisdomTree US SmallCap Fund
0.02%
Proshares Ultra Russell 2000
0.02%
ProShares UltraPro Russell2000
0.02%
FlexShares Morningstar US Market Factor Tilt Index Fund
0.02%
Invesco Russell 1000 Equal Weight ETF
0%
Fidelity MSCI Health Care Index ETF
0%
View more
Humankind US Stock ETF
Proportion0.14%
Invesco S&P SmallCap 600 QVM Multi-factor ETF
Proportion0.06%
Vanguard US Value Factor ETF
Proportion0.04%
iShares Morningstar Small-Cap Value ETF
Proportion0.03%
WisdomTree US SmallCap Fund
Proportion0.02%
Proshares Ultra Russell 2000
Proportion0.02%
ProShares UltraPro Russell2000
Proportion0.02%
FlexShares Morningstar US Market Factor Tilt Index Fund
Proportion0.02%
Invesco Russell 1000 Equal Weight ETF
Proportion0%
Fidelity MSCI Health Care Index ETF
Proportion0%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
